PHINMA University of Pangasinan

College of Health Sciences

Name of Student Nurse: Basto, Rea Mae F. Date: September 24, 2021
Level/block/group: 4BSN1 Hospital/Area: Clinical Instructor: Virgie Ferrer Bauzon, RN, MAN

NAME OF DRUG MECHANISM OF ACTION CONTRAINDICATIONS SIDE EFFECTS ADVERSE EFFECTS NURSING RESPONSIBILITIES
GENERIC NAME
Lanthanum carbonate is a  Patients with  Nausea  Constipation  Monitor serum calcium
Lanthanum Carbonate phosphate binder that reduces acute peptic  Vomiting  Dialysis graft and phosphorus levels
ulcer  Stomach pain complications/ periodically
BRAND NAME absorption of phosphate by
 Ulcerative  Fever and occlusion  Instruct client to take
Fosrenol
forming insoluble lanthanum colitis chills  Hypertension drug with immediately
CLASSIFICATION phosphate complexes that pass  Crohn’s  Loss of  Bronchitis after meals and to chew
Pharmacologic class: disease appetite  Hypercalcemia tablets completely before
Phosphate binder through the gastrointestinal (GI)
 Bowel  Hematochezia  Rhinitis swallowing
Therapeutic class: Renal tract unabsorbed. Both serum
obstruction  Advise patient to discuss
and genitourinary agent
phosphate and calcium including ileus any planned dietary
Pregnancy risk category
C phosphate product are reduced and fecal changes with prescriber
INDICATION impaction  Inform female patient
as a consequence of the reduced
Fosrenol is a phosphate with childbearing
binder indicated to dietary phosphate absorption. potential that drug isn’t
reduce serum recommended during
phosphate in patients pregnancy
with end-stage renal  Instruct female patient to
disease (ESRD))
tell prescriber if she is
DOSAGE & FREQUENCY breastfeeding
Pedia:
Not recommended
Adult:
Chewable tablets:
500mg, 750 mg and
1000mg
Oral powder: 750mg
and 1000mg